Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
R1578, RG1578
print preview
bookmark
share with colleague
General Information
Company
Roche
Description
Metabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Molecular Target
Metabotropic glutamate receptor subtype 2 (mGluR2) (GRM2)
Mechanism of Action
Metabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Latest Stage of Development
Phase II
Indication
Depression
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy